The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database

被引:0
|
作者
Aaron Scott
Paolo Goffredo
Timothy Ginader
Jennifer Hrabe
Irena Gribovskaja-Rupp
Muneera R. Kapadia
Ronald J. Weigel
Imran Hassan
机构
[1] University of Iowa Hospitals & Clinics,Department of Surgery
[2] University of Iowa,Holden Comprehensive Cancer Center Biostatistics Core
来源
Journal of Gastrointestinal Surgery | 2020年 / 24卷
关键词
KRAS; Stages I–III colon cancer; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1402 / 1410
页数:8
相关论文
共 50 条
  • [21] Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
    Zocche, David M.
    Ramirez, Carolina
    Fontao, Fernando M.
    Costa, Lucas D.
    Redal, Maria A.
    FRONTIERS IN GENETICS, 2015, 6
  • [22] Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database
    Mao, Rui
    Zhao, Hong
    Li, Kan
    Luo, Sheng
    Turner, Megan
    Cai, Jian-Qiang
    Blazer, Dan, III
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2722 - 2729
  • [23] Impact of KRAS Mutation on Survival Outcome of Patients With Metastatic Colorectal Cancer in Jordan
    Alkader, Mohammad S.
    Altaha, Rashed Z.
    Badwan, Sinan A.
    Halalmeh, Anees I.
    Al-Khawaldeh, Muna H.
    Atmeh, Mousa T.
    Jabali, Eslam H.
    Attieh, Ola
    Al-Soudi, Hana S.
    Alkhatib, Lean A.
    Alrawashdeh, Mohammad T.
    Abdelqader, Aseel F.
    Ashokaibi, Omar Y.
    Shahin, Ahmed A.
    Maaita, Fadi M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [24] Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database
    Dutta, Sunil W.
    Alonso, Clayton E.
    Jones, Taylor C.
    Waddle, Mark R.
    Janowski, Einsley-Marie
    Trifiletti, Daniel M.
    CLINICAL COLORECTAL CANCER, 2018, 17 (04) : 297 - 306
  • [25] The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer
    Fitzgerald, Timothy L.
    Rangan, Swathi
    Dobbs, Larry
    Starr, Shane
    Sigounas, George
    JOURNAL OF SURGICAL RESEARCH, 2014, 192 (01) : 82 - 89
  • [26] Chemotherapy use in stage III colon cancer: a National Cancer Database analysis
    Upadhyay, Smrity
    Dahal, Sumit
    Bhatt, Vijaya Raj
    Khanal, Nabin
    Silberstein, Peter T.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2015, 7 (05) : 244 - 251
  • [27] Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
    Kim, Seung Tae
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    CANCER RESEARCH AND TREATMENT, 2014, 46 (01): : 48 - 54
  • [28] Synchronous metastatic colon cancer and the importance of primary tumor laterality-A National Cancer Database analysis of right-versus left-sided colon cancer
    Zhao, Beiqun
    Lopez, Nicole E.
    Eisenstein, Samuel
    Schnickel, Gabriel T.
    Sicklick, Jason K.
    Ramamoorthy, Sonia L.
    Clary, Bryan M.
    AMERICAN JOURNAL OF SURGERY, 2020, 220 (02) : 408 - 414
  • [29] Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study
    Majed, B.
    Moreau, T.
    Senouci, K.
    Sigal, B.
    Salmon, R. J.
    Fourquet, A.
    Asselain, B.
    BULLETIN DU CANCER, 2009, 96 (05) : 531 - 541
  • [30] Significance of inflammation-based indices in the prognosis of patients with non-metastatic colorectal cancer
    Song, Xiangping
    Zhu, Hong
    Pei, Qian
    Tan, Fengbo
    Li, Chenglong
    Zhou, Zhongyi
    Zhou, Yuan
    Yu, Nanhui
    Li, Yuqiang
    Pei, Haiping
    ONCOTARGET, 2017, 8 (28) : 45178 - 45189